{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:36:11Z","timestamp":1785825371369,"version":"3.56.0"},"reference-count":64,"publisher":"BMJ","issue":"suppl 4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tob Control"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:p>This paper reviews the tobacco industry\u2019s litigation strategy for addressing the addiction issue through trial testimony by its experts, and opening and closing statements by its lawyers. Despite the fact that several companies now claim to accept, in varying degrees, the conclusions of the Surgeon General concerning tobacco addiction, the tobacco industry litigation strategy pertaining to addiction is essentially unchanged since that of the early 1980s when the issue emerged as crucial. The industry uses its experts and the process of cross-examination of plaintiff\u2019s experts to imply that the addictiveness of tobacco and nicotine are more comparable to substances such as caffeine, chocolate, and even milk, than to heroin, cocaine and alcohol. Furthermore, the tobacco industry contends that the definition of addiction has now become so broadened as to include carrots and caffeine and hence that any concurrence that smoking is addictive, does not imply that cigarettes are addictive to the standards that drugs such as heroin and cocaine are addictive. Finally, the industry has continuously asserted that tobacco users assumed the risks of tobacco since they understood that quitting could be difficult when they began to use, and moreover, that the main barrier to cessation is lack of desire or motivation to quit and not physical addiction. These positions have been maintained through the 2004\u20132005 US Government litigation that was ongoing as the time of this writing.<\/jats:p>","DOI":"10.1136\/tc.2005.013789","type":"journal-article","created":{"date-parts":[[2006,11,28]],"date-time":"2006-11-28T03:37:58Z","timestamp":1164685078000},"page":"iv27-iv36","source":"Crossref","is-referenced-by-count":25,"title":["Tobacco industry litigation position on addiction: continued dependence on past views"],"prefix":"10.1136","volume":"15","author":[{"given":"Jack E","family":"Henningfield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine A","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"Zeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2006,11,27]]},"reference":[{"key":"2024051409242056000_15.suppl_4.iv27.1","unstructured":"Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, United States Congress. Hearings on Regulation of Tobacco Products, 14 April 1994."},{"key":"2024051409242056000_15.suppl_4.iv27.2","unstructured":"Henningfield JE. Written direct testimony. United States of America v. Phillip Morris USA Inc., et al. 5 November 2004."},{"key":"2024051409242056000_15.suppl_4.iv27.3","unstructured":"Szymanczyk ME. Deposition. Engle v. R. J. Reynolds Tobacco Co. 12 Jun 2000."},{"key":"2024051409242056000_15.suppl_4.iv27.4","unstructured":"Henningfield JE. Trial testimony. United States of America v. Phillip Morris USA Inc. , et al. 22, 23, 29, 30 November; 1 December 2004."},{"key":"2024051409242056000_15.suppl_4.iv27.5","unstructured":"Kessler D. A question of intent: A great American battle with a deadly industry. New York: Public Affairs, 2001."},{"key":"2024051409242056000_15.suppl_4.iv27.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530030045033"},{"key":"2024051409242056000_15.suppl_4.iv27.7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.13.1173"},{"key":"2024051409242056000_15.suppl_4.iv27.8","unstructured":"Hilts PJ. Smokescreen: The truth behind the tobacco industry cover-up. Reading, Massachusetts: Addison-Wesley Publishing Company, Inc, 1996."},{"key":"2024051409242056000_15.suppl_4.iv27.9","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2003.006890"},{"key":"2024051409242056000_15.suppl_4.iv27.10","unstructured":"World Health Organization. Scientific Advisory Committee on Tobacco Product Regulation (SACTob). Recommendation on health claims derived from ISO\/FTC method to measure cigarette yield. Geneva: World Health Organization 2002."},{"key":"2024051409242056000_15.suppl_4.iv27.11","unstructured":"National Cancer Institute. Risks associated with smoking cigarettes with low-machine measured yields of tar and nicotine. Smoking and Tobacco Control Monograph No. 13. Bethesda, Maryland: US Department of Health and Human Services, National Institutes of Health, National Caner Institutes, 2001, (NIH Publication No. 02\u20135074)."},{"key":"2024051409242056000_15.suppl_4.iv27.12","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2005.014076"},{"key":"2024051409242056000_15.suppl_4.iv27.13","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2004.009928"},{"key":"2024051409242056000_15.suppl_4.iv27.14","first-page":"41314","volume":"60","year":"1995","journal-title":"Federal Register"},{"key":"2024051409242056000_15.suppl_4.iv27.15","first-page":"44396","volume":"61","year":"1996","journal-title":"Federal Register"},{"key":"2024051409242056000_15.suppl_4.iv27.16","first-page":"43","volume":"53","year":"1998","journal-title":"FDLJ"},{"key":"2024051409242056000_15.suppl_4.iv27.17","unstructured":"World Health Organization, Oslo. Advancing knowledge on regulating tobacco products (monograph). Geneva: World Health Organization, 2001."},{"key":"2024051409242056000_15.suppl_4.iv27.18","unstructured":"Broder JM. Cigarette maker concedes smoking can cause cancer. New York Times. 21 March 1997. http:\/\/query.nytimes.com\/gst\/fullpage.html?sec=health&res=9C02E2DA173BF932A15750C0A961958260 (accessed February 15 2006)."},{"key":"2024051409242056000_15.suppl_4.iv27.19","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2004.046227"},{"key":"2024051409242056000_15.suppl_4.iv27.20","unstructured":"US Smokeless Tobacco. Petition to the United States Federal Trade Commission.5 February 2002. http:\/\/www.ussmokeless.com\/UST%20FTC%20Letter%20Final.PDF (accessed 2 August 2005)."},{"key":"2024051409242056000_15.suppl_4.iv27.21","unstructured":"Roswell Park Cancer Institute, RPCI Tobacco Institute Document Scanning Project. http:\/\/roswell.tobaccodocuments.org\/about_TI.htm (accessed 21 July 2005)."},{"key":"2024051409242056000_15.suppl_4.iv27.22","unstructured":"United States Department of Justice, closing statements. United States of America v. Philip Morris USA Inc., et al. 8\u20139 June 2005."},{"key":"2024051409242056000_15.suppl_4.iv27.23","unstructured":"US Department of Health and Human Services. The health consequences of smoking: nicotine addiction. A report of the Surgeon General, 1988. Rockville, Maryland: Public Health Service, Centers for Disease Control, Office on Smoking and Health, 1988, (DHHS Publication No (CDC) 88-8406)."},{"key":"2024051409242056000_15.suppl_4.iv27.24","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994."},{"key":"2024051409242056000_15.suppl_4.iv27.25","unstructured":"World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Geneva: World Health Organization, 1992."},{"key":"2024051409242056000_15.suppl_4.iv27.26","unstructured":"Royal Society of Canada. Tobacco nicotine and addiction: a committee report prepared at the request of the Royal Society of Canada. Ottawa: Royal Society of Canada, 1989."},{"key":"2024051409242056000_15.suppl_4.iv27.27","unstructured":"Royal College of Physicians of London. Nicotine addiction in Britain: a report of the Tobacco Advisory Group of the Royal College of Physicians. London: Royal College of Physicians, 2000."},{"key":"2024051409242056000_15.suppl_4.iv27.28","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2006.016667"},{"key":"2024051409242056000_15.suppl_4.iv27.29","unstructured":"Jafee JH. Trial testimony. Cipollone v. Liggett Group Inc. 2 March 1988."},{"key":"2024051409242056000_15.suppl_4.iv27.30","unstructured":"Blau T. Deposition. Cipollone v. Liggett Group Inc. 2 January 1988."},{"key":"2024051409242056000_15.suppl_4.iv27.31","unstructured":"Henningfield JE. Deposition. Marsee v. United States Tobacco Co. Case No. Civ-84-2777R. District Court for the Western District of Oklahoma."},{"key":"2024051409242056000_15.suppl_4.iv27.32","doi-asserted-by":"crossref","unstructured":"Daynard RA. Roles of tobacco litigation in societal change. In: Boyle P, Gray N, Henningfield JH, Seffrin J, Zatonski W, eds. Tobacco and public health: science and policy. Oxford: Oxford University Press, 2004:695\u2013705.","DOI":"10.1093\/oso\/9780198526872.003.0040"},{"key":"2024051409242056000_15.suppl_4.iv27.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01072.x"},{"key":"2024051409242056000_15.suppl_4.iv27.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01168.x"},{"key":"2024051409242056000_15.suppl_4.iv27.35","doi-asserted-by":"publisher","DOI":"10.1080\/14622200412331324839"},{"key":"2024051409242056000_15.suppl_4.iv27.36","unstructured":"Blau T. Statement for the record by Dr. Theodore H. Blau for the Subcommittee on Health and the Environment of the Committee on Energy and Commerce U.S. House of Representatives. March 17 1983."},{"key":"2024051409242056000_15.suppl_4.iv27.37","unstructured":"Carchman RA. Deposition. LOCAL NO. 17 Bridge & Iron Workers Insurance Fund v. Philip Morris Inc. 7 January 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.38","unstructured":"Carchman RA. Trial testimony. Williams v. Philip Morris Inc. 16 March 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.39","unstructured":"Robinson JH. Deposition. Minnesota v. Philip Morris Inc. 22 August 1997."},{"key":"2024051409242056000_15.suppl_4.iv27.40","unstructured":"Rowell PP. Trial testimony. Minnesota v. Philip Morris Inc. 16 April 1998."},{"key":"2024051409242056000_15.suppl_4.iv27.41","unstructured":"Debethizy JD. Deposition. Small\/Fubini v. Lorillard Tobacco Co.; Hoskins v. R.J. Reynolds Tobacco Co.; Hoberman v. Brown & Williamson Tobacco Corp.; Frosina v. Philip Morris Inc.; Zito v. American Tobacco Co. 25 September 1997."},{"key":"2024051409242056000_15.suppl_4.iv27.42","unstructured":"Ellis CL. Congressional Testimony. Hearings before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce House of Representatives One Hundred Third Congress. Serial No. 103\u2013149. 25 March;14 April 1994:656."},{"key":"2024051409242056000_15.suppl_4.iv27.43","unstructured":"Ellis CL. Video Deposition. Mike Moore, Attorney General, State of Mississippi et al. , v. The American Tobacco Company et al. Video transcript by A. William Roberts Jr. and Associates, Charleston: NC, 20 March, 1997."},{"key":"2024051409242056000_15.suppl_4.iv27.44","unstructured":"Harris Louis S. Testimony before the U.S. Food and Drug Administration Drug Abuse Advisory Committee, Meeting 27, Abuse liability assessment of nicotine nasal spray, 1 August 1994."},{"key":"2024051409242056000_15.suppl_4.iv27.45","unstructured":"Cloninger CR. Trial testimony. Engle v. R.J. Reynolds Tobacco Co. 19 April 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.46","unstructured":"Ciraulo D. Trial testimony. Raulerson [Connor] v. R.J. Reynolds Tobacco Co. 30 April 1997."},{"key":"2024051409242056000_15.suppl_4.iv27.47","unstructured":"Benowitz NE. Trial testimony. United States of America v. Philip Morris USA Inc. 2 November 2004."},{"key":"2024051409242056000_15.suppl_4.iv27.48","unstructured":"Rowell PP. Trial testimony. United States of America v. Philip Morris USA Inc., et al. 25 March 2005."},{"key":"2024051409242056000_15.suppl_4.iv27.49","unstructured":"Wilson, Theodore A. Affidavit in The Circuit Court of Kanawha County, West Virginia, James E. McCune v. American Tobacco Company, Inc. , et al. (Civil Action No. 97\u2013C\u2013204) 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.50","unstructured":"Opening statements. Minnesota v Philip Morris USA Inc. 26 January 1998."},{"key":"2024051409242056000_15.suppl_4.iv27.51","unstructured":"Defense\u2019s closing statement. Reller v. Philip Morris Inc. 23 July 2003."},{"key":"2024051409242056000_15.suppl_4.iv27.52","unstructured":"Defense\u2019s closing statement. LOCAL NO. 17 Bridge & Iron Workers Insurance Fund v. Philip Morris Inc. 16 March 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.53","first-page":"127","volume":"III","year":"2002","journal-title":"YJHP, Law and Ethics"},{"key":"2024051409242056000_15.suppl_4.iv27.54","unstructured":"World Health Organization Scientific Advisory Committee on Tobacco Product Regulation. Statement of principles guiding the evaluation of new or modified tobacco products. Geneva, Switzerland: World Health Organization Tobacco Free Initiative, 2003."},{"key":"2024051409242056000_15.suppl_4.iv27.55","doi-asserted-by":"crossref","first-page":"ii64","DOI":"10.1136\/tc.11.suppl_2.ii64","volume":"11","year":"2002","journal-title":"Tob Control"},{"key":"2024051409242056000_15.suppl_4.iv27.56","unstructured":"Defense\u2019s opening statement. Engle v. R.J. Reynolds Tobacco Co. 20 October 1998."},{"key":"2024051409242056000_15.suppl_4.iv27.57","unstructured":"Defense\u2019s opening statement.Schwarz v. Philip Morris Inc. 6 February 2002."},{"key":"2024051409242056000_15.suppl_4.iv27.58","unstructured":"Defense\u2019s opening statement.Williams v. Philip Morris Inc. 24 February 1999."},{"key":"2024051409242056000_15.suppl_4.iv27.59","unstructured":"Defense\u2019s opening statement. Eastman v. Brown & Williamson Tobacco Corp. 13 March 2003."},{"key":"2024051409242056000_15.suppl_4.iv27.60","unstructured":"Defense\u2019s closing statement. Kenyon v. R. J. Reynolds Co. 10 December 2001."},{"key":"2024051409242056000_15.suppl_4.iv27.61","doi-asserted-by":"publisher","DOI":"10.1136\/tc.2004.010082"},{"key":"2024051409242056000_15.suppl_4.iv27.62","unstructured":"Defense\u2019s opening statement. Blankenship v. Philip Morris, Inc. 10 September 2001."},{"key":"2024051409242056000_15.suppl_4.iv27.63","unstructured":"Tobacco Industry Closing statements. United States of America v. Philip Morris USA Inc., et al. June 2005."},{"key":"2024051409242056000_15.suppl_4.iv27.64","first-page":"509","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Tobacco Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/tc.2005.013789","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T16:24:41Z","timestamp":1715703881000},"score":1,"resource":{"primary":{"URL":"https:\/\/tobaccocontrol.bmj.com\/lookup\/doi\/10.1136\/tc.2005.013789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11,27]]},"references-count":64,"journal-issue":{"issue":"suppl 4","published-online":{"date-parts":[[2006,11,27]]},"published-print":{"date-parts":[[2006,12]]}},"alternative-id":["10.1136\/tc.2005.013789"],"URL":"https:\/\/doi.org\/10.1136\/tc.2005.013789","relation":{},"ISSN":["0964-4563","1468-3318"],"issn-type":[{"value":"0964-4563","type":"print"},{"value":"1468-3318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11,27]]}}}